Clinical Evidence on Dietary Fiber and GLP-1 Receptor Agonists
Dietary fiber GLP-1 receptor agonist effects are emerging as a complementary approach in metabolic health. This evidence highlights the potential role of fermentable fibers in appetite regulation. Family medicine clinicians should consider dietary fiber…
Medicinal Cannabis Doesn’t Help Anxiety, Depression, or PTSD, Huge Review Finds
A large systematic review found limited evidence for cannabis in treating mental health disorders such as anxiety, depression, and PTSD. This challenges the widespread use of medicinal cannabis for these psychiatric conditions. Clinicians should…
GLP-1 Receptor Agonist Evidence: Weight Loss & Marriage Risk
GLP-1 receptor agonist psychosocial outcomes are important for understanding the effects of weight loss on relationships. Significant weight loss can lead to shifts in self-perception and interpersonal dynamics. Clinicians should consider counseling…
Medical Cannabis for Chronic Pain: Promise, Pharmacology, and Persistent Gaps
This 2025 medical cannabis chronic pain review examines the pharmacology and clinical evidence for cannabinoids in pain management. While promising, significant gaps remain in standardized dosing and long-term safety data. The review highlights the need…
Acute and Long-Term Psychiatric Consequences of Synthetic Cannabinoids and Related Novel Psychoactive Substances: A Systematic Review
This systematic review examines psychiatric consequences synthetic cannabinoids cause, highlighting both acute and long-term effects. Synthetic cannabinoids present significant psychiatric risks distinct from natural cannabis. Understanding these…
Comparative Effectiveness, Safety, and Acceptability of Cannabis Use Disorder Treatments
This cannabis use disorder treatment research analyzes pharmacological and psychosocial interventions through a network meta-analysis. It highlights the limited evidence for medication effectiveness and supports psychosocial approaches. The study guides…
Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study.
This study focuses on shared decision-making cannabis arthritis to develop a decision aid supporting patients and clinicians. Arthritis patients often seek cannabis when conventional treatments provide partial relief. The decision aid aims to facilitate…
Cannabis and Sleep Review, Read Carefully
This paper is a systematic review and meta-analysis on recreational cannabis use and sleep in the general population. It brings together observational and experimental studies and finds that poorer sleep outcomes appear more often in observational data…
Survey of 47 Trials Maps Cannabinoid Research in Neurology—But Evidence Gaps Remain Large
This review maps cannabinoid clinical trials neurology, highlighting 47 completed studies focused on conditions such as Multiple Sclerosis and Fibromyalgia. It reveals significant evidence gaps due to non-standardized protocols and outcome measures. The…
First Systematic Typology of Cannabis Harm Reduction Strategies Maps a Fragmented Field
This 2024 scoping review presents a cannabis harm reduction typology that classifies legal, organizational, and health-related strategies. It highlights the fragmented field and the lack of effectiveness data. The typology provides a foundation for…
